Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weltens

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Breast Cancer Research and Treatment|November 22, 2017
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional studyO Brouckaert, K Van Asten, A Laenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersO Brouckaert, A Laenen, J Vanderhaegen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.
Breast Cancer Research and Treatment|July 15, 2009
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen usersA S Dieudonné, D Lambrechts, B Claes, et al.
Breast Cancer Research and Treatment|October 5, 2017
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter studyO Kaidar-Person, I Meattini, P Jain, et al.
Breast Cancer Research and Treatment|August 10, 2007
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancerP Neven, B Van Calster, I Van den Bempt, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Breast Cancer Research and Treatment|November 22, 2017
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional studyO Brouckaert, K Van Asten, A Laenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersO Brouckaert, A Laenen, J Vanderhaegen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.
Breast Cancer Research and Treatment|July 15, 2009
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen usersA S Dieudonné, D Lambrechts, B Claes, et al.
Breast Cancer Research and Treatment|October 5, 2017
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter studyO Kaidar-Person, I Meattini, P Jain, et al.
Breast Cancer Research and Treatment|August 10, 2007
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancerP Neven, B Van Calster, I Van den Bempt, et al.
Pageof 3